Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
about
Achievement of therapeutic goals with low-dose imiglucerase in Gaucher disease: a single-center experience.Gaucher's disease: report of 11 cases with review of literature.Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3)Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose - response relationships.Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience.
P2860
Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
@en
Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
@nl
type
label
Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
@en
Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
@nl
prefLabel
Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
@en
Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
@nl
P2093
P1433
P1476
Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?
@en
P2093
Ellen Sidransky
Gregory M Pastores
Motomi Mori
P2888
P356
10.1097/GIM.0B013E3181928F6A
P407
P577
2009-02-01T00:00:00Z
P6179
1044245773